TECH OUTLOOKDecember - 20195IN MY OPINION08CXO INSIGHTSRevolutionizing Genome Editing with CRISPRMark Behlke, CSO, Integrated DNA Technologies23Pioneering Production and Delivery Solutions to Address the Complexities of Cell TherapyChristina Yi, Chief Operations Officer, DendreonC O NT E NT S26Pg 10 - 11IN F CUSDoing More with Digital: It's Just Good BusinessMatt Lasmanis, US CIO, GSK [LSE:GSK] [NYSE:GSK]
< Page 4 | Page 6 >